| __timestamp | Pharming Group N.V. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4042025 | 381287000 |
| Thursday, January 1, 2015 | 5279557 | 452612000 |
| Friday, January 1, 2016 | 8073913 | 316800000 |
| Sunday, January 1, 2017 | 44864073 | 330100000 |
| Monday, January 1, 2018 | 53488904 | 265800000 |
| Tuesday, January 1, 2019 | 65896361 | 336200000 |
| Wednesday, January 1, 2020 | 69968267 | 423900000 |
| Friday, January 1, 2021 | 92047281 | 467000000 |
| Saturday, January 1, 2022 | 131819000 | 487000000 |
| Sunday, January 1, 2023 | 87501000 | 477100000 |
Unleashing insights
In the competitive landscape of the pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, United Therapeutics Corporation and Pharming Group N.V. have demonstrated contrasting approaches to SG&A efficiency.
United Therapeutics, a leader in innovative therapies, consistently allocated a significant portion of its budget to SG&A, peaking at approximately 487 million in 2022. This strategic investment reflects their commitment to robust marketing and administrative frameworks, essential for sustaining their market position.
Conversely, Pharming Group N.V., known for its niche biopharmaceutical products, exhibited a more conservative SG&A strategy. Their expenses grew from a modest 4 million in 2014 to around 132 million in 2022, indicating a gradual scaling of operations.
This analysis underscores the diverse strategies employed by pharmaceutical companies in balancing growth and operational efficiency.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Pharming Group N.V.
Comparing SG&A Expenses: Novartis AG vs Pharming Group N.V. Trends and Insights
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Pharming Group N.V.
Comparing SG&A Expenses: Alnylam Pharmaceuticals, Inc. vs Pharming Group N.V. Trends and Insights
United Therapeutics Corporation vs Sarepta Therapeutics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Verona Pharma plc
United Therapeutics Corporation vs Ultragenyx Pharmaceutical Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Alkermes plc
Selling, General, and Administrative Costs: United Therapeutics Corporation vs Geron Corporation
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Pharming Group N.V.
Comparing SG&A Expenses: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: Pharming Group N.V. vs BioCryst Pharmaceuticals, Inc.